# Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)

> **NCT01283009** · PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 584 (actual)

## Conditions studied

- Community Acquired Respiratory Disease Syndrome

## Interventions

- **DRUG:** Inactive Substance
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT01283009
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-09
- **Primary completion:** 2016-07-31
- **Final completion:** 2016-08-31
- **Target enrollment:** 584 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283009, "Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01283009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*